[Acquired hemophilia: current status in Japan and immuno-biochemical features of autoantibodies to factor VIII].
Tanaka
Ichiro
I
Shima
Noritoshi
N
D001323:Autoantibodies / Q000276:immunology; D019774:Blood Coagulation Factor Inhibitors / Q000097:blood / Q000502:physiology / Q000627:therapeutic use; D001779:Blood Coagulation Factors / Q000627:therapeutic use; D001780:Blood Coagulation Tests; D003894:Deamino Arginine Vasopressin / Q000627:therapeutic use; D000939:Epitopes; D005167:Factor VII / Q000627:therapeutic use; D005169:Factor VIII / Q000276:immunology*; D006467:Hemophilia A / Q000097:blood / Q000209:etiology* / Q000628:therapy; D006801:Humans; D007564:Japan; D010951:Plasma Exchange; D011994:Recombinant Proteins / Q000627:therapeutic use
D001323:Autoantibodies; D019774:Blood Coagulation Factor Inhibitors; D001779:Blood Coagulation Factors; D000939:Epitopes; D011994:Recombinant Proteins; C025667:prothrombin complex concentrates; D005167:Factor VII; D005169:Factor VIII; D003894:Deamino Arginine Vasopressin